Exploratory study of nocebo effect in senior medical students
Background
Νocebo Effect is known to induce adverse symptoms after negative expectations which can be manifested on a physical and psychological level. As 6th year medical students often face a wide range of clinical challenges and may be prone to negative expectations or beliefs affecting their pre-clinical and clinical success, we want to investigate how they are affected by the Nocebo Effect.
Objective
To investigate whether a nocebo effect can be induced when exposing final-year students to the clinical context of their training.
Methods
We used verbal suggestions as a nocebo mechanism and by using three tools, the Illness Attitude Scales, the Symptom Checklist-90, and the State-Trait Anxiety Inventory, we examined the difference in scores on measures of psychometric parameters in 33 participants who were on their 6th year medical and attended three clinics for the first time during their education. The administrations were given before and after attending each clinic, and negative verbal suggestions were given prior to the first administration. We also measured whether the overall number of clinics, had an effect on psychometric parameters.
Results
The results revealed a significant increase in second administration overall in the three clinics in specific psychometric parameters but no statistically significant difference was observed after attending consecutive clinics.
Conclusion
Students reported the occurrence of adverse symptoms in the investigated psychometric parameters, which should be noted in order to avoid potential educational clinical failure.
1. Blasini M, Corsi N, Klinger R, Colloca L. Nocebo and pain: An overview of the psychoneurobiological mechanisms. Pain Rep. 2017;2(2):e585. doi:10.1097/PR9.0000000000000585
2. Faasse K, Huynh A, Pearson S, Geers AL, Helfer SG, Colagiuri B. The Influence of Side Effect Information Framing on Nocebo Effects. Ann Behav Med. 2019;53(7):621-629. doi:10.1093/abm/kay071
3. Enck P, Benedetti F, Schedlowski M. New insights into the placebo and nocebo responses. Neuron. 2008;59(2):195-206. doi:10.1016/j.neuron.2008.06.030
4. Höfler C, Potthoff J, Schienle A. A Direct Comparison of Placebo and Nocebo Effects on Visuospatial Attention: An Eye-Tracking Experiment. Front Psychiatry. 2019;10:446. doi:10.3389/fpsyt.2019.00446
5. Benedetti F, Lanotte M, Lopiano L, Colloca L. When words are painful: unraveling the mechanisms of the nocebo effect. Neuroscience. 2007;147(2):260-271. doi:10.1016/j.neuroscience.2007.02.020
6. Schweiger A, Parducci A. Nocebo: the psychologic induction of pain. Pavlov J Biol Sci. 1981;16(3):140-143. doi:10.1007/BF03003218
7. Stovner LJ, Oftedal G, Straume A, Johnsson A. Nocebo as headache trigger: evidence from a sham-controlled provocation study with RF fields. Acta Neurol Scand Suppl. 2008;188:67-71. doi:10.1111/j.1600-0404.2008.01035.x
8. Flaten MA, Simonsen T, Olsen H. Drug-related information generates placebo and nocebo responses that modify the drug response. Psychosom Med. 1999;61(2):250-255. doi:10.1097/00006842-199903000-00018
9. Bräscher AK, Witthöft M. Nocebo hyperalgesia induced by implicit conditioning. J Behav Ther Exp Psychiatry. 2019;64(Sep):106-112. doi:10.1016/j.jbtep.2019.03.006
10. Johansen O, Brox J, Flaten MA. Placebo and Nocebo responses, cortisol, and circulating beta-endorphin. Psychosom Med. 2003;65(5):786-790. doi:10.1097/01.psy.0000082626.56217.cf
11. Goubert L, Vlaeyen JW, Crombez G, Craig KD. Learning about pain from others: an observational learning account. J Pain. 2011;12(2):167-174. doi:10.1016/j.jpain.2010.10.001
12. Verrender A, Loughran SP, Dalecki A, Freudenstein F, Croft RJ. Can explicit suggestions about the harmfulness of EMF exposure exacerbate a nocebo response in healthy controls? Environ Res. 2018;166(Oct):409-417. doi:10.1016/j.envres.2018.06.032
13. Turnwald BP, Goyer JP, Boles DZ, Silder A, Delp SL, Crum AJ. Learning one’s genetic risk changes physiology independent of actual genetic risk. Nat Hum Behav. 2019;3(1):48-56. doi:10.1038/s41562-018-0483-4
14. Crichton F, Chapman S, Cundy T, Petrie KJ. The Link between Health Complaints and Wind Turbines: Support for the Nocebo Expectations Hypothesis. Front Public Health. 2014;2:220. doi:10.3389/fpubh.2014.00220
15. Geers AL, Close S, Caplandies FC, Vase L. A Positive Mood Induction for Reducing the Formation of Nocebo Effects from Side Effect Information. Ann Behav Med. 2019;53(11):999-1008. doi:10.1093/abm/kaz005
16. Di Blasi Z, Harkness E, Ernst E, Georgiou A, Kleijnen J. Influence of context effects on health outcomes: A systematic review. The Lancet (London, England). 2001;357(9258):757-762.
17. Wager TD, Atlas LY. The neuroscience of placebo effects: connecting context, learning and health. Nat Rev Neurosci. 2015;16(7):403-418. doi:10.1038/nrn3976
18. Colloca L, Miller FG. How placebo responses are formed: a learning perspective. Philos Trans R Soc Lond B Biol Sci. 2011;366(1572):1859-1869. doi:10.1098/rstb.2010.0398
19. Bartlett J, Fowler K. Beyond the curriculum: a cross-sectional study of medical student psychological distress, and health care needs, practices and barriers. Soc Psychiatry Psychiatr Epidemiol. 2020;55(9):1215-1221. doi:10.1007/s00127-019-01771-1
20. Ludwig AB et al. Depression and stress amongst undergraduate medical students. BMC Med Educ. 2015;27(20):141. doi:10.1186/s12909-015-0425-z
21. Ross S, von Fragstein M, Cleland J. Medical students’ illness-related cognitions. Med Educ. 2011;45(12):1241-1250. doi:10.1111/j.1365-2923.2011.04079.x
22. Thommen M, Westkämper R, Schaufelberger J, Grichting C. Concepts of health and illness in entering medical students; first part of a prospective study. Soz Praventivmed. 1996;41(2):90-97. doi:10.1007/BF01323087
23. Gaston-Hawkins LA, Solorio FA, Chao GF, Green CR. The Silent Epidemic: Causes and Consequences of Medical Learner Burnout. Curr Psychiatry Rep. 2020;22(12):86. doi:10.1007/s11920-020-01211-x
24. Shapiro SL, Shapiro DE, Schwartz GE. Stress management in medical education: a review of the literature. Acad Med. 2000;75(7):748-759. doi:10.1097/00001888-200007000-00023
25. Huebner LA, Royer JA, Moore J. The assessment and remediation of dysfunctional stress in medical school. J Med Educ. 1981;56(7):547-558. doi:10.1097/00001888-198107000-00002
26. Sirri L, Grandi S, Fava GA. The Illness Attitude Scales. A clinimetric index for assessing hypochondriacal fears and beliefs. Psychother Psychosom. 2008;77(6):337-350. doi:10.1159/000151387
27. Ntonias S, Karastergiou A, Manos N. Rating of the Symptom Checklist-90 psychopathology scale in a Greek population. Psychiatriky. 1991;2:42-48.
28. Liakos A, Giannitsi S. The reliability and validity of the modified Greek Spielberger anxiety scale. Engephalos. 1984;21:71-76.
29. Webster RK, Weinman J, Rubin GJ. A systematic review of factors that contribute to nocebo effects. Health Psychol. 2016;35(12):1334-1355. doi:10.1037/hea0000416
30. Bartels DJP, van Laarhoven AIM, Stroo M, et al. Minimizing nocebo effects by conditioning with verbal suggestion: A randomized clinical trial in healthy humans. PLoS One. 2017;12(9):e0182959. doi:10.1371/journal.pone.0182959
31. Petersen GL, Finnerup NB, Colloca L, et al. The magnitude of nocebo effects in pain: a meta-analysis. Pain. 2014;155(8):1426-1434. doi:10.1016/j.pain.2014.04.016
32. Aslaksen PM, Lyby PS. Fear of pain potentiates nocebo hyperalgesia. J Pain Res. 2015;8:703-710. doi:10.2147/JPR.S91923
33. Vögtle E, Barke A, Kröner-Herwig B. Nocebo hyperalgesia induced by social observational learning. Pain. 2013;154(8):1427-1433. doi:10.1016/j.pain.2013.04.041
34. Quinn VF, Livesey EJ, Colagiuri B. Latent Inhibition Reduces Nocebo Nausea, Even Without Deception. Ann Behav Med. 2017;51(3):432-441. doi:10.1007/s12160-016-9867-8
35. Faasse K, Grey A, Jordan R, Garland S, Petrie KJ. Seeing is believing: Impact of social modeling on placebo and nocebo responding. Health Psychol. 2015;34(8):880-885. doi:10.1037/hea0000199
36. Rief W, Avorn J, Barsky AJ. Medication-attributed adverse effects in placebo groups: implications for assessment of adverse effects. Arch Intern Med. 2006;166(2):155-160. doi:10.1001/archinte.166.2.155
37. Colloca L, Sigaudo M, Benedetti F. The role of learning in nocebo and placebo effects. Pain. 2008;136(1-2):211-218. doi:10.1016/j.pain.2008.02.006
38. Colloca L, Benedetti F. Nocebo hyperalgesia: how anxiety is turned into pain. Curr Opin Anaesthesiol. 2007;20(5):435-439. doi:10.1097/ACO.0b013e3282b972fb
39. Van den Bergh O, Witthöft M, Petersen S, Brown RJ. Symptoms and the body: Taking the inferential leap. Neurosci Biobehav Rev. 2017;74(Pt A):185-203. doi:10.1016/j.neubiorev.2017.01.015
40. Rooney T, Sharpe L, Todd J, Richmond B, Colagiuri B. The relationship between expectancy, anxiety, and the nocebo effect: a systematic review and meta-analysis with recommendations for future research. Health Psychol Rev. 2023;17(4):550-577. doi:10.1080/17437199.2022.2125894
41. Rutherford BR, Wall MM, Glass A, Stewart JW. The role of patient expectancy in placebo and nocebo effects in antidepressant trials. J Clin Psychiatry. 2014;75(10):1040-1046. doi:10.4088/JCP.13m08797
42. Mitsikostas DD, Mantonakis L, Chalarakis N. Nocebo in clinical trials for depression: a metaanalysis. Psychiatry Res. 2014;215(1):82-86. doi:10.1016/j.psychres.2013.10.019
43. Cassiello – Robbins C, Barlow DH. Anger: The unrecognized emotion in emotional disorders. Clin Psychol. 2016;23:66-82. doi:10.1111/cpsp.12139
44. Barefoot JC, Dahlstrom WG, Williams RB Jr. Hostility, CHD incidence, and total mortality: a 25year follow-up study of 255 physicians. Psychosom Med. 1983;45(1):59-63. doi:10.1097/00006842-198303000-00008
45. Olatunji BO, Ciesielski BG, Tolin DF. Fear and loathing: a meta-analytic review of the specificity of anger in PTSD. Behav Ther. 2010;41(1):93-105. doi:10.1016/j.beth.2009.01.004